Skip to main content
Premium Trial:

Request an Annual Quote

Syngenta Donates Arabidopsis Seed Lines to Ohio State Center, Deposits Sequence Info in GenBank

NEW YORK, May 27 (GenomeWeb News) - Syngenta has donated 48,000 seed lines in its Arabidopsis functional genomics seed collection to the Arabidopsis Biological Resource Center hosted at Ohio State University, the company said today.


The ARBC and the Nottingham Arabidopsis Stock Centre in Nottingham, UK will jointly distribute the seed lines to researchers.


The company is also depositing the sequence information from these seed lines into GenBank, and said the collection would be available to GenBank users "in late-May."


"The donation contains novel seeds that we currently do not have in our collection. It will im­prove our understanding of how individual genes can influence a plant's growth," Randy Scholl, Director of the ABRC, said in a statement.

The ARBC, established in 1991 with a National Science Foundation grant, collects, preserves, and distributes Arabidopsisseeds and related plant materials.

This is not the first time Syngenta has made private sequence publicly available. In 2002, the company announced it had completed a draft sequence of the japonica rice genome, and would deposit this sequence information into GenBank once a more complete sequence was obtained.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.